Additionally, we provide multimodal predictive models combining video, audio, and physiological inputs.

We study the recent progress on dynamic view synthesis (DVS) from monocular video. Though existing approaches have demonstrated impressive results, we show a discrepancy between the practical capture process and the existing experimental protocols, which effectively leaks in multi-view signals during training. We define effective multi-view factors (EMFs) to quantify the amount of multi-view signal present in the input capture sequence based on the relative camera-scene motion. We introduce two new metrics: co-visibility masked image metrics and correspondence accuracy, which overcome the issue in existing protocols. We also propose a new iPhone dataset that includes more diverse real-life deformation sequences. Using our proposed experimental protocol, we show that the state-of-the-art approaches observe a 1-2 dB drop in masked PSNR in the absence of multi-view cues and 4-5 dB drop when modeling complex motion. Code and data can be found at http://hangg7.com/dycheck.

The performance of machine learning models in drug discovery is highly dependent on the quality and consistency of the underlying training data. Due to limitations in dataset sizes, many models are trained by aggregating bioactivity data from diverse sources, including public databases such as ChEMBL. However, this approach often introduces significant noise due to variability in experimental protocols. We introduce AssayMatch, a framework for data selection that builds smaller, more homogenous training sets attuned to the test set of interest. AssayMatch leverages data attribution methods to quantify the contribution of each training assay to model performance. These attribution scores are used to finetune language embeddings of text-based assay descriptions to capture not just semantic similarity, but also the compatibility between assays. Unlike existing data attribution methods, our approach enables data selection for a test set with unknown labels, mirroring real-world drug discovery campaigns where the activities of candidate molecules are not known in advance. At test time, embeddings finetuned with AssayMatch are used to rank all available training data. We demonstrate that models trained on data selected by AssayMatch are able to surpass the performance of the model trained on the complete dataset, highlighting its ability to effectively filter out harmful or noisy experiments. We perform experiments on two common machine learning architectures and see increased prediction capability over a strong language-only baseline for 9/12 model-target pairs. AssayMatch provides a data-driven mechanism to curate higher-quality datasets, reducing noise from incompatible experiments and improving the predictive power and data efficiency of models for drug discovery. AssayMatch is available at https://github.com/Ozymandias314/AssayMatch.

We considered the following hyperparameters when performing a grid search. Beyond learning rate and number of gradient steps, we also evaluated using a simple "threshold" by performing adaptation only when the marginal entropy was greater than ResNext-101 models without any additional tuning, except we use B = 32 due to memory limits. The TT A results are obtained using the same AugMix augmentations as for MEMO. We obtain the baseline ResNet-50 and ResNext-101 (32x8d) parameters directly from the torchvision library. One may wonder: are augmentations needed in the first place?

Additionally, we provide multimodal predictive models combining video, audio, and physiological inputs.

We considered the following hyperparameters when performing a grid search. Beyond learning rate and number of gradient steps, we also evaluated using a simple "threshold" by performing adaptation only when the marginal entropy was greater than ResNext-101 models without any additional tuning, except we use B = 32 due to memory limits. The TT A results are obtained using the same AugMix augmentations as for MEMO. We obtain the baseline ResNet-50 and ResNext-101 (32x8d) parameters directly from the torchvision library. One may wonder: are augmentations needed in the first place?

This article introduces WebXAII, an open-source web framework designed to facilitate research on human interaction with eXplainable Artificial Intelligence (XAI) systems. The field of XAI is rapidly expanding, driven by the growing societal implications of the widespread adoption of AI (and in particular machine learning) across diverse applications. Researchers who study the interaction between humans and XAI techniques typically develop ad hoc interfaces in order to conduct their studies. These interfaces are usually not shared alongside the results of the studies, which limits their reusability and the reproducibility of experiments. In response, we design and implement WebXAII, a web-based platform that can embody full experimental protocols, meaning that it can present all aspects of the experiment to human participants and record their responses. The experimental protocols are translated into a composite architecture of generic views and modules, which offers a lot of flexibility. The architecture is defined in a structured configuration file, so that protocols can be implemented with minimal programming skills. We demonstrate that WebXAII can effectively embody relevant protocols, by reproducing the protocol of a state-of-the-art study of the literature.

Brain-computer interfaces (BCIs) provide alternative communication methods for individuals with motor disabilities by allowing control and interaction with external devices. Non-invasive BCIs, especially those using electroencephalography (EEG), are practical and safe for various applications. However, their performance is often hindered by EEG non-stationarities, caused by changing mental states or device characteristics like electrode impedance. This challenge has spurred research into adaptive BCIs that can handle such variations. In recent years, interest has grown in using error-related potentials (ErrPs) to enhance BCI performance. ErrPs, neural responses to errors, can be detected non-invasively and have been integrated into different BCI paradigms to improve performance through error correction or adaptation. This research introduces a novel adaptive ErrP-based BCI approach using reinforcement learning (RL). We demonstrate the feasibility of an RL-driven adaptive framework incorporating ErrPs and motor imagery. Utilizing two RL agents, the framework adapts dynamically to EEG non-stationarities. Validation was conducted using a publicly available motor imagery dataset and a fast-paced game designed to boost user engagement. Results show the framework's promise, with RL agents learning control policies from user interactions and achieving robust performance across datasets. However, a critical insight from the game-based protocol revealed that motor imagery in a high-speed interaction paradigm was largely ineffective for participants, highlighting task design limitations in real-time BCI applications. These findings underscore the potential of RL for adaptive BCIs while pointing out practical constraints related to task complexity and user responsiveness.

We study the recent progress on dynamic view synthesis (DVS) from monocular video. Though existing approaches have demonstrated impressive results, we show a discrepancy between the practical capture process and the existing experimental protocols, which effectively leaks in multi-view signals during training. We define effective multi-view factors (EMFs) to quantify the amount of multi-view signal present in the input capture sequence based on the relative camera-scene motion. We introduce two new metrics: co-visibility masked image metrics and correspondence accuracy, which overcome the issue in existing protocols. We also propose a new iPhone dataset that includes more diverse real-life deformation sequences.